Presentation is loading. Please wait.

Presentation is loading. Please wait.

Proteomic biomarkers for ovarian cancer risk in women with polycystic ovary syndrome: a systematic review and biomarker database integration  Nicolas.

Similar presentations


Presentation on theme: "Proteomic biomarkers for ovarian cancer risk in women with polycystic ovary syndrome: a systematic review and biomarker database integration  Nicolas."— Presentation transcript:

1 Proteomic biomarkers for ovarian cancer risk in women with polycystic ovary syndrome: a systematic review and biomarker database integration  Nicolas Galazis, B.M.B.S., Olalekan Olaleye, F.M.C.O.G., Zeina Haoula, M.R.C.O.G., Robert Layfield, Ph.D., William Atiomo, D.M.  Fertility and Sterility  Volume 98, Issue 6, Pages e1 (December 2012) DOI: /j.fertnstert Copyright © 2012 American Society for Reproductive Medicine Terms and Conditions

2 Figure 1 Flow chart summarizing the selection process of the primary studies in which proteomic methodologies were used for the identification of biomarkers in OC. Fertility and Sterility  , e1DOI: ( /j.fertnstert ) Copyright © 2012 American Society for Reproductive Medicine Terms and Conditions

3 Supplemental Figure 1 Flow chart summarizing the selection process of the primary studies in which proteomic methodologies were used for the identification of biomarkers in PCOS used to update the PCOS proteomic biomarker database. Fertility and Sterility  , e1DOI: ( /j.fertnstert ) Copyright © 2012 American Society for Reproductive Medicine Terms and Conditions


Download ppt "Proteomic biomarkers for ovarian cancer risk in women with polycystic ovary syndrome: a systematic review and biomarker database integration  Nicolas."

Similar presentations


Ads by Google